Adult
PO
Initially, 5 mg 4-6 hrly may increase as necessary. Extended-release tab: 5-10 mg 12 hrly. Max: 400 mg/day.
IV
Injection: 1-10 mg over 1-2 min, repeated not more often than 4 hrly.
Infusion. Initial: 2 mg/hr, increased as necessary. Patient-controlled analgesia (PCA): 0.03 mg/kg, admin w/ a minimum lock-out time of 5 min.
SC
Injection. Initial: 5 mg 4 hrly.
Infusion. Initial: 7.5 mg/day adjusted according to response.
Adverse drug reactions: nausea, constipation, vomiting, respiratory depression, headache, pruritus, insomnia, dizziness, asthenia, somnolence, abdominal pain, chills and fever, hypotension, anorexia, diarrhea, dyspepsia, dysphagia, anxiety, nervousness, tremor, vasodilation, cough, dyspnea, rash.
See also
Instructions and conversion table and
Opioid dose conversion Adapted from CIMS Drug Information System. Internet. Accessed on January 10, 2016.